Search research articles
Contact Us
Filters
Showing results (211-220 of 252) with videos related to
Page
of 26
Sort By:
The New England Journal of Medicine
|
September 14, 2000
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation
R Childs, A Chernoff, N Contentin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1988
Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study
S L Topalian, D Solomon, F P Avis, et al.
The New England Journal of Medicine
|
April 9, 1987
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone
S A Rosenberg, M T Lotze, L M Muul, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 19, 1997
Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice
J R Gnarra, J M Ward, F D Porter, et al.
AJR. American Journal of Roentgenology
|
December 1, 1992
The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients
P L Choyke, G M Glenn, M M Walther, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer
A L Feldman, L Tamarkin, G F Paciotti, et al.
The Journal of Urology
|
August 24, 1999
Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma
M M Walther, R Reiter, H R Keiser, et al.
Neurology
|
January 1, 1991
Central nervous system involvement in Von Hippel-Lindau disease
M R Filling-Katz, P L Choyke, E Oldfield, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 10, 2001
Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes
G Eisenhofer, M M Walther, T T Huynh, et al.
Annals of Internal Medicine
|
March 1, 1996
Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis
C Talar-Williams, Y M Hijazi, M M Walther, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 252) with videos related to
Sort By:
Page
of 26
The New England Journal of Medicine
|
September 14, 2000
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation
R Childs, A Chernoff, N Contentin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1988
Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study
S L Topalian, D Solomon, F P Avis, et al.
The New England Journal of Medicine
|
April 9, 1987
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone
S A Rosenberg, M T Lotze, L M Muul, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 19, 1997
Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice
J R Gnarra, J M Ward, F D Porter, et al.
AJR. American Journal of Roentgenology
|
December 1, 1992
The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients
P L Choyke, G M Glenn, M M Walther, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer
A L Feldman, L Tamarkin, G F Paciotti, et al.
The Journal of Urology
|
August 24, 1999
Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma
M M Walther, R Reiter, H R Keiser, et al.
Neurology
|
January 1, 1991
Central nervous system involvement in Von Hippel-Lindau disease
M R Filling-Katz, P L Choyke, E Oldfield, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 10, 2001
Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes
G Eisenhofer, M M Walther, T T Huynh, et al.
Annals of Internal Medicine
|
March 1, 1996
Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis
C Talar-Williams, Y M Hijazi, M M Walther, et al.
Page
of 26